Akili Labs is an award-winning biotechnology company specialising in molecular diagnostic systems development, founded by Charles Faul and Lucas Lotter in 2017, with Dr Farhan Pervaiz joining as a co-founder in 2018.

Based in South Africa with international affiliates, Akili Labs was established after realising the need for easy access to fast-paced diagnostics in the healthcare system.

With innovation and collaboration at the forefront of its company purpose, Akili Labs constantly forges partnerships with organisations around the globe for the development, creation and implementation of

Rubber Nano Products (RNP) holds technology that allows for the creation of chemically specific activators vulcanisation with sulfur. These accelerator classes are based on the chemical species forming the active portion of the accelerator. RNP technology allows for variation of the substrate used and can create activators from almost any material used in rubber. Stearic acid is among the many possibilities. The RNP products allow for the reduction and rationalisation of zinc oxide and zinc content in rubber article manufacture. These are advantages that can also be leveraged as cure press

Innovus manages the commercialisation of the University innovation and intellectual property portfolio through patenting, licensing and the formation of spin-out companies. We carry out all technology transfer, entrepreneurial support and development and innovation at the University. One of South Africa's oldest university tech transfer offices and one of its most successful, we have spun out 23 companies, licensed 67 technologies and filed 114 international patents.